A brief intervention to prevent smoking relapse in cardiac patients: a randomised controlled trial

ISRCTN ISRCTN13036545
DOI https://doi.org/10.1186/ISRCTN13036545
Protocol serial number HB115
Sponsor Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Funder NHS Cardiovascular Disease and Stroke National Research and Development Programme (UK)
Submission date
23/01/2004
Registration date
23/01/2004
Last edited
17/09/2010
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Peter Hajek
Scientific

Psychology Section
Department of Human Science
St. Bartholomew's and the Royal London School of Medicine
Turner Street
London
E1 2AD
United Kingdom

Phone +44 (0)20 7377 7345
Email P.Hajek@mds.qmw.ac.uk

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Scientific title
Study objectivesThis was a randomised controlled trial of a routinely deliverable, relapse-prevention intervention with cardiac in-patients who smoked prior to hospital admission. The question was whether a brief intervention designed to be implemented as a part of routine care on a national basis is feasible and powerful enough to make an impact on this hard-to-reach group in terms of continuous long-term biochemically validated abstinence.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedCardiovascular diseases: Heart disease
Intervention1. Multimodal intervention included, in addition to the personal advice, a relapse prevention booklet, quiz about its contents, an offer to join a 'buddy' support system, signing a declaration of commitment not to smoke, and carbon monoxide monitoring.
2. Usual care
Intervention typeOther
Primary outcome measure(s)

Continuous abstinence for 6 weeks and 12 months, biochemically validated by expired air CO. The delivery of the various parts of the intervention was monitored.

Key secondary outcome measure(s)

Not provided at time of registration

Completion date01/04/2000

Eligibility

Participant type(s)Patient
Age groupAdult
SexAll
Target sample size at registration540
Key inclusion criteria1. 540 smokers hospitalised after myocardial infarction or cardiac bypass surgery
2. Current smokers or recent ex-smokers (defined as stopping smoking up to six months earlier) at the time of their hospital admission
3. Had not smoked at all since their hospital admission
4. Sufficiently recovered to receive the intervention,
5. No gross memory impairment
6. Under 76 years of age
7. Could read English
8. Motivated to remain abstinent from smoking after their discharge from the hospital
Key exclusion criteriaDoes not match inclusion criteria
Date of first enrolment01/01/1996
Date of final enrolment01/04/2000

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Psychology Section
London
E1 2AD
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 12/01/2002 Yes No